The global minimally invasive surgical instruments market size was estimated at US$ 28 billion in 2022 and it is expected to hit US$ 77.73 billion by 2032, poised to grow at a CAGR of 10.80% from 2023 to 2032.
Access our Premium Real Time Data Intelligence Tool, Visit: Precedence Statistics
The global minimally invasive surgical instruments market size was valued at US$ 6.90 billion in 2022 and it is expected to hit US$ 19.33 billion by 2032, poised to grow at a CAGR of 10.90% from 2023 to 2032.
North America led the market in 2022 with revenue share of 44%. The minimally invasive surgical instruments market in this region is expanding due to the growing prevalence of various kind of disorders. Heart disease is the biggest cause of mortality in the U.S. as per an updated report published by the Centers for Disease Control and Prevention in September 2022. About 18.2 million American adults aged 20 and above have coronary artery disease and approximately 360,900 people died from coronary heart disorder in 2019. In addition, adoption of innovative technologies is also driving the growth of minimally invasive surgical instruments market in North America region.
Asia-Pacific, on the other hand, is expected to develop at the fastest rate during the forecast period. China and Japan dominate the minimally invasive surgical instruments market in Asia-Pacific region. The factors such as rapid urbanization, growing geriatric population, and growing trend of medical tourism are boosting the growth of minimally invasive surgical instruments market in this region. In addition, the increase in healthcare expenditure is paving way for the expansion of Asia-Pacific minimally invasive surgical instruments market.
Due to benefits of minimally invasive surgical procedures such as fewer serious operative and post operative problems and quicker recovery times are driving the demand for minimally invasive surgical instruments in the global market. In addition, the growing prevalence of chronic disorders is also driving the growth of the global minimally invasive surgical instruments market. As per the World Health Organization (WHO) statistics report for 2021, non-communicable disorders often known as chronic disorders kill around 41 million people each year, accounting for roughly 71% of all deaths worldwide. According to the same source, non-communicable disorders claim the lives of nearly 15 million people aged 30 to 69 years old every year around the globe. Thus, the rising burden of non-communicable diseases is driving the demand for minimally invasive surgical operations. This is directly impacting the expansion of global minimally invasive surgical instruments market over the forecast period.
The impact of the coronavirus outbreak on the growth of global minimally invasive surgical instruments market was quite negative. This is attributed to the supply chain disruptions and trade restrictions. In addition, the hospitals visits have been lowered in number as compared to previous year. Thus, the growing number of vaccinations had negative outlook on the expansion of global minimally invasive surgical instruments market.
The major market players are adopting marketing strategies for the development of global minimally invasive surgical instruments market. The key strategies such as new product launch, mergers, collaborations, and acquisitions are creating market position for market players in global minimally invasive surgical instruments market. For example, Fujifilm Medical Systems USA Inc. introduced its ELUXEO surgical system in July 2020, which combines the company’s endoscopic and minimally invasive surgeries and allows surgeons to perform all type of endoscopic surgeries from a single component with improved visualization.
The growth of global minimally invasive surgical instruments market is attributed to the growing research and development initiatives for the launch of new minimally invasive surgical instruments in the global market. In addition, the government of developed regions is also investing in the development of minimally invasive surgical instruments. All of these aforementioned factors are boosting the growth of the global minimally invasive surgical instruments market.
| Report Coverage | Details |
| Market Size by 2032 | USD 77.73 Billion |
| Growth Rate from 2023 to 2032 |
CAGR of 10.80% |
| North America Market Share in 2022 | 44% |
| Orthopedic Segment Hit The Revenue Share in 2022 | 25% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Device, Application, End Use, Geography |
| Companies Mentioned |
The Johns Hopkins Hospital, Apollo Hospitals Enterprise Ltd., The General Hospital Corporation, Bedfordshire Hospitals, Stanford Healthcare, Circle Health Ltd., Singapore General Hospital Ltd., Manipal Health Enterprises Pvt. Ltd, Mount Elizabeth Hospital, King Fahd Medical City |
The handheld instruments segment accounted largest revenue share in 2022. The handheld instruments segment is growing due to technological developments especially due to adoption of robotics. These minimally invasive surgical instruments are cost effective when compared to other types of minimally invasive surgical instruments. In addition, handheld instruments are easy to operate. All of these aforementioned factors are driving the growth of the segment.
The electrosurgical devices segment is expected to witness strong growth during forecast period. Due to rising frequency of chronic disorders, the ageing population, and the rise in the number of minimally invasive surgical processes, the electrosurgical devices segment is predicted to grow fast throughout the projected period. The demand for cosmetic operations is growing and one key driver driving demand and acceptance of electrosurgical devices in the global market is the rising use of electrosurgical devices in minimally invasive cosmetic surgeries.
The orthopedic segment dominated the market in 2022 with 25% revenue share. The orthopedic minimally invasive surgical processes are quite less risky as compared to traditional surgical methods. As a result, minimally invasive surgical instruments are used in critical orthopedic operations. Due to these factors, minimally invasive surgical instruments are highly adopted by surgeons and orthopedic surgeons.
The cardiac surgery segment is projected to hit strong growth from 2023 to 2032. The minimally invasive operations have a number of advantages over traditional surgeries including less pain and blood loss. In addition, the growing prevalence of cardiovascular disorders is considered as key factor driving the demand for minimally invasive surgical instruments for cardiac surgery.
The hospital segment accounted revenue share of around 67% in 2022. The market for minimally invasive surgical instruments is expanding due to growing number of hospitals globally. Moreover, the government all around the globe is taking efforts for the development of healthcare facilities. In addition, the rising prevalence of chronic disorders are also contributing towards the growth of the segment.
The ambulatory surgical centers segment is expected to hit remarkable growth during the forecast period. The growing number of ambulatory surgical centers is driving the growth of global minimally invasive surgical instruments market. As per the government records, there are 5,500 ambulatory surgical centers in the U.S. The ambulatory surgical centers are considered as cost effective option as compared to hospitals. The favorable reimbursement policies is driving the adoption of minimally invasive surgical instruments in ambulatory surgical centers on a large scale.
Key Developments
Some of the prominent players in the global minimally invasive surgical instruments market include:
Segments Covered in the Report
(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)
By Device
By Application
By End Use
By Geography
PROCEED TO BUY :
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
